| Now Published: Our Phase II Clinical Trial Results Hello, We are excited to share that results of our Phase II stem cell treatment study have been published in the peer-reviewed journal, Stem Cell Research & Therapy. You can read the full study here, or see recent media coverage from the Daily Mail, National MS Society, and Business Wire. Undergoing rigorous peer review ensures that the research methods, data, and conclusions of our study are sound and reliable, signaling to other scientists that our work can be trusted and expanded upon. The added credibility of publishing also helps us reach a broader scientific readership and archives the work so that it is accessible for future research and reference. The results show improvements in multiple areas – including walking speed, bladder function, and gray matter volume retention – for patients with significant disability. The research is the first Phase II placebo-controlled, double-blind stem cell trial in the U.S. to investigate the use of stem cell-derived treatments for disabled patients with progressive disease that do not have active lesions or ongoing relapses. |
| READ MORE of this study at the National MS Society Website found here: https://www.nationalmssociety.org/news-and-magazine/news/stem-cell-trial-results-published |
| ======================================== |
 |
